|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.045 NOK | -0.48% |
|
-7.52% | -43.05% |
Company Valuation: NEXT Biometrics Group ASA
Data adjusted to current consolidation scope
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 154.6 | 197.8 | 723.4 | 413.5 | 738.6 | 792.3 |
| Change | - | 28.01% | 265.64% | -42.84% | 78.64% | 7.27% |
| Enterprise Value (EV) 1 | 73.84 | 141.1 | 624.3 | 346.2 | 672.4 | 733.1 |
| Change | - | 91.08% | 342.44% | -44.54% | 94.24% | 9.02% |
| P/E ratio | -0.89x | -1.64x | -11.7x | -8.91x | -10.3x | -16.3x |
| PBR | 1.15x | 2.04x | 5.39x | 4.31x | 7.83x | 6.67x |
| PEG | - | 0x | 0.2x | 0.4x | -0.3x | 0.4x |
| Capitalization / Revenue | 1.83x | 3.42x | 14.3x | 8.56x | 21.5x | 11.1x |
| EV / Revenue | 0.87x | 2.44x | 12.3x | 7.17x | 19.6x | 10.2x |
| EV / EBITDA | -0.48x | -1.62x | -11.8x | -8.1x | -11.2x | -17.1x |
| EV / EBIT | -0.45x | -1.43x | -10.7x | -7.2x | -10.3x | -15.9x |
| EV / FCF | -1.09x | -2.89x | -33.6x | -20.1x | -19.7x | -13.9x |
| FCF Yield | -91.8% | -34.6% | -2.98% | -4.99% | -5.08% | -7.18% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -4.024 | -1.584 | -0.6725 | -0.5048 | -0.6908 | -0.4219 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 84.44 | 57.79 | 50.76 | 48.29 | 34.38 | 71.57 |
| EBITDA 1 | -152.4 | -86.88 | -52.91 | -42.73 | -60.28 | -42.78 |
| EBIT 1 | -164.6 | -98.62 | -58.25 | -48.07 | -65.28 | -46.07 |
| Net income 1 | -166.4 | -101.8 | -60.01 | -46.33 | -65.73 | -45.24 |
| Net Debt 1 | -80.71 | -56.74 | -99.11 | -67.26 | -66.13 | -59.2 |
| Reference price 2 | 3.600 | 2.605 | 7.890 | 4.495 | 7.100 | 6.880 |
| Nbr of stocks (in thousands) | 42,931 | 75,944 | 91,681 | 91,981 | 104,025 | 115,155 |
| Announcement Date | 21/04/20 | 21/04/21 | 27/04/22 | 20/04/23 | 24/04/24 | 11/04/25 |
1NOK in Million2NOK
Estimates
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- NEXT Stock
- Valuation NEXT Biometrics Group ASA
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















